Isarna Therapeutics has announced positive data from its international multicenter study evaluating ISTH0036, a selective TGF-β2-blocking antisense oligonucleotide, in...
Cellino, a pioneering biotechnology company focused on autonomous biomanufacturing for personalized regenerative medicine, has announced its strategic expansion into...
Marea Therapeutics, Inc., a clinical-stage biotechnology company, has announced its upcoming participation in the 93rd European Atherosclerosis Society (EAS)...